SONDRA SMITH: Open Payments
NPI 1164759957 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 43 payments from 11 companies in 2025. Trend: 2023 $611 · 2024 $1,190 · 2025 $917
Food & beverage: $917
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $331 |
| Novo Nordisk Inc | 6 | $201 |
| Exact Sciences Corporation | 4 | $87 |
| Amgen Inc. | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: VRAYLAR, Wegovy, Cologuard Collection Kit, Ozempic, QULIPTA, UBRELVY, REPATHA, CAPLYTA.
Industry payments across FL — which companies pay providers there.
